重庆申高生化制药股份有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
27
NMPA:27
Drug Approvals
Paracetamol,Caffeine and Aspirin Powder
- Product Name
- 阿咖酚散
- Approval Number
- 国药准字H50021879
- Approval Date
- Sep 28, 2020
NMPA
Compound Saccharated Pepsin Granules
- Product Name
- 复方胃蛋白酶颗粒
- Approval Number
- 国药准字H50021717
- Approval Date
- Sep 28, 2020
NMPA
Compound Paracetamol and Chlorphenamine Tablets for Infant
- Product Name
- 小儿氨酚那敏片
- Approval Number
- 国药准字H50021777
- Approval Date
- Sep 28, 2020
NMPA
Paracetamol,Caffeine and Aspirin Powder
- Product Name
- 阿咖酚散
- Approval Number
- 国药准字H20067953
- Approval Date
- Sep 27, 2020
NMPA
Compound Sulfadiazine Tablets
- Product Name
- 复方磺胺嘧啶片
- Approval Number
- 国药准字H50020389
- Approval Date
- Sep 25, 2020
NMPA
Paracetamol, Aminophenazone Phenacetin,Caffeine and Chlorphenamine Maleate Granules
- Product Name
- 酚氨咖敏颗粒
- Approval Number
- 国药准字H50021932
- Approval Date
- Sep 25, 2020
NMPA
Compound Paracetamol and Amantadine Hydrochloride Capsules
- Product Name
- 复方氨酚烷胺胶囊
- Approval Number
- 国药准字H50021229
- Approval Date
- Sep 25, 2020
NMPA
Paracetamol,Caffein,Atificial Cow-bezoar and chlorphenamine Maleate capsules
- Product Name
- 氨咖黄敏胶囊
- Approval Number
- 国药准字H50021716
- Approval Date
- Sep 25, 2020
NMPA
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
No trials found
News
No news found